Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chemotherapeutic properties of prominent nitrofurans.

Literature DB >> 802123

Chemotherapeutic properties of prominent nitrofurans.

R E Chamberlain.

Abstract

Entities: Chemical

Mesh：

Substances：
Nitrofurans

Year: 1976 PMID： 802123 DOI： 10.1093/jac/2.4.325

Source DB: PubMed Journal: J Antimicrob Chemother ISSN： 0305-7453 Impact factor: 5.790

Keyword Cloud
Cited

× No keyword cloud information.

16 in total

1. Synthesis and antimicrobial activity of new furan derivatives.

Authors: H A El-Obeid; E I Elnima; A A Al-Badr
Journal: Pharm Res Date: 1985-01 Impact factor: 4.200

2. In vitro selection of resistant Helicobacter pylori.

Authors: C E Haas; D E Nix; J J Schentag
Journal: Antimicrob Agents Chemother Date: 1990-09 Impact factor: 5.191

3. A Novel Mechanism of Inactivating Antibacterial Nitro Compounds in the Human Pathogen Staphylococcus aureus by Overexpression of a NADH-Dependent Flavin Nitroreductase.

Authors: Ebaa M El-Hossary; Konrad U Förstner; Patrice François; Damien Baud; Karin Streker; Jacques Schrenzel; Knut Ohlsen; Ulrike Holzgrabe
Journal: Antimicrob Agents Chemother Date: 2018-01-25 Impact factor: 5.191

4. Isolation of nitrofurantoin-resistant mutants of nitroreductase-producing Clostridium sp. strains from the human intestinal tract.

Authors: F Rafii; E B Hansen
Journal: Antimicrob Agents Chemother Date: 1998-05 Impact factor: 5.191

Chemotherapeutic properties of prominent nitrofurans.

1. Synthesis and antimicrobial activity of new furan derivatives.

2. In vitro selection of resistant Helicobacter pylori.

3. A Novel Mechanism of Inactivating Antibacterial Nitro Compounds in the Human Pathogen Staphylococcus aureus by Overexpression of a NADH-Dependent Flavin Nitroreductase.

4. Isolation of nitrofurantoin-resistant mutants of nitroreductase-producing Clostridium sp. strains from the human intestinal tract.

5. Novel 5-Nitrofuran-Activating Reductase in Escherichia coli.

Review 6. An update on the role of nitrofurans in the management of urinary tract infections.

7. Sister chromatid exchanges in peripheral lymphocytes of urinary tract infection treated with nitrofurantoin.

8. Furazolidone and nitrofurantoin in the treatment of experimental Pneumocystis carinii pneumonia.

9. Efficacy of a single dose of furazolidone for treatment of cholera in children.

10. Susceptibility of clinical isolates of Campylobacter pylori to twenty-one antimicrobial agents.